ReviewHeliyon2024
Amended biochar in constructed wetlands: Roles, challenges, and future directions removing pharmaceuticals and personal care products.
Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CoFeMicroorganisms · 2026Article
- Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques.Antibiotics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceuticals and personal care products (PPCPs) in wastewater pose significant threats to both human health and aquatic ecosystems. Wastewater discharge from various sources is the primary cause of these contaminants, and proper treatment is essential for protecting the environment. Traditional treatment technologies are often too expensive and ineffective in removing PPCPs. Constructed wetlands (CWs) offer a sustainable, cost-efficient alternative for wastewater treatment, though their capability to eliminate PPCPs can vary based on multiple aspects. Recent studies highlight biochar-a carbon-rich material resultant from biomass pyrolysis-as a promising amendment to improve CW performance. However, there is a deficiency of proper literature reviews on using biochar in CWs specifically for PPCP removal. This review focuses on biochar's role in CWs and its effectiveness in removing PPCPs and enhancing microbial activity and nutrient cycling. A bibliometric analysis using Vosviewer software was used to assess the current research trends in the biochar-amended CWs to attenuate PPCPs. While biochar shows potential in eliminating PPCPs, challenges, such as optimizing its application and addressing long-term operational concerns for treating emerging pollutants like PPCPs. Future research should enhance biochar production and low-cost techniques for diverse groups of PPCPs and perform field trials to validate laboratory results under actual conditions exploring microbial-biochar and plant-biochar interactions. Addressing these challenges is crucial to advancing biochar-amended CWs and enhancing wastewater treatment on a global scale.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.